Showing results (131-140 of 200) with videos related to
Sort By:
Pageof 20
Surgical Case Reports|February 2, 2019
Carcinosarcoma of Vater's papilla: case report of a rare neoplasm and review of the literatureRumi Itoyama, Yo-Ichi Yamashita, Yosuke Nakao, et al.Surgical Case Reports|September 15, 2015
Hepatic angiomyolipoma with special attention to radiologic imagingKunitaka Kuramoto, Toru Beppu, Tomohiro Namimoto, et al.Anticancer Research|February 4, 2019
Neuroendocrine Tumor of the Hilar Bile DuctNaoki Umezaki, Daisuke Hashimoto, Yo-Ichi Yamashita, et al.The Journal of Cell Biology|July 2, 2008
Involvement of autophagy in trypsinogen activation within the pancreatic acinar cellsDaisuke Hashimoto, Masaki Ohmuraya, Masahiko Hirota, et al.Journal of Gastroenterology|July 17, 2010
Detection of liver metastases secondary to pancreatic cancer: utility of combined helical computed tomography during arterial portography with biphasic computed tomography-assisted hepatic arteriographyYoshiaki Ikuta, Hiroshi Takamori, Osamu Ikeda, et al.Cancer Research|October 1, 2015
An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell-like Behaviors Contributing to Disease ProgressionHiromitsu Hayashi, Takaaki Higashi, Naomi Yokoyama, et al.Cancers|March 10, 2022
Intraperitoneal Paclitaxel Treatment for Patients with Pancreatic Ductal Adenocarcinoma with Peritoneal Dissemination Provides a Survival BenefitTomohisa Yamamoto, Sohei Satoi, So Yamaki, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 11, 2017
Clinical significance of half-lives of tumor markers α-fetoprotein and des-γ-carboxy prothrombin after hepatectomy for hepatocellular carcinomaMasayo Tsukamoto, Hidetoshi Nitta, Katsunori Imai, et al.Journal of Hepato-Biliary-Pancreatic Sciences|October 24, 2014
Poor outcomes after hepatectomy in patients with ascites infected by methicillin-resistant staphylococciHidetoshi Nitta, Toru Beppu, Akari Itoyama, et al.Journal of Clinical and Translational Hepatology|June 30, 2017
The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular CarcinomaToru Beppu, Shigeki Nakagawa, Hidetoshi Nitta, et al.Pageof 20